{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:49:11Z","timestamp":1767998951005,"version":"3.49.0"},"reference-count":11,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"DOI":"10.1515\/cclm-2015-0890","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T17:00:26Z","timestamp":1447866026000},"page":"e187-e189","source":"Crossref","is-referenced-by-count":3,"title":["The importance of angiogenic markers in the differential diagnosis of HELLP syndrome vs. non-HELLP thrombocytopenia"],"prefix":"10.1515","volume":"54","author":[{"given":"Covadonga","family":"Quir\u00f3s","sequence":"first","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Laboratorio de Medicina, Hospital Universitario central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Laboratorio de Medicina, Hospital Universitario central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Prieto","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Laboratorio de Medicina, Hospital Universitario central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Laboratorio de Medicina, Hospital Universitario central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Vaquerizo","sequence":"additional","affiliation":[{"name":"Servicio de Obstetricia y Ginecolog\u00eda, Hospital Universitario central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco V.","family":"\u00c1lvarez Men\u00e9ndez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Laboratorio de Medicina, Hospital Universitario central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"key":"2023010208471973711_j_cclm-2015-0890_ref_001_w2aab2b8c85b1b7b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Reimer T, Rohrmann H, Stubert J, Pecks U, Glocker MO, Richter DU, et al. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. J Matern Fetal Neonatal Med 2013;26:263\u20139.","DOI":"10.3109\/14767058.2012.733747"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_002_w2aab2b8c85b1b7b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obst Gynecol 2004;103:981\u201391.","DOI":"10.1097\/01.AOG.0000126245.35811.2a"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_003_w2aab2b8c85b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Sep S, Verbeek J, Koek G, Smits L, Spaanderman M, Peeters L. Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol 2010;202:271.e1\u2013271.e5.","DOI":"10.1016\/j.ajog.2009.10.874"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_004_w2aab2b8c85b1b7b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"V\u00e1rbonyi T, Nagy B, F\u00fcle T, Tarca AL, Karaszi K, Schonleber J, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 2011;32(Suppl):S21\u20139.","DOI":"10.1016\/j.placenta.2010.04.014"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_005_w2aab2b8c85b1b7b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. New Engl J Med 2006;355:1056\u20138.","DOI":"10.1056\/NEJMe068161"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_006_w2aab2b8c85b1b7b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"Young B, Levine RJ, Salahuddin S, Qian C, Lim KH, Karumanchi SA, et al. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med 2010;23:366\u201370.","DOI":"10.3109\/14767050903184207"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_007_w2aab2b8c85b1b7b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Schaarschmidt W, Rana S, Stepan H. The course of angiogenic factors in early vs. late onset preeclampsia and HELLP syndrome. J Perinat Med 2013;41:511\u20136.","DOI":"10.1515\/jpm-2012-0248"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_008_w2aab2b8c85b1b7b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampasia. Hypertension 2014;63:346\u201352.","DOI":"10.1161\/HYPERTENSIONAHA.113.01787"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_009_w2aab2b8c85b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Alvarez-Fernandez I, Prieto B, Rodr\u00edguez V, Ruano Y, Escudero AI, \u00c1lvarez FV. New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis. Clin Chem Lab Med 2014;52:1159\u201368.","DOI":"10.1515\/cclm-2013-0901"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_010_w2aab2b8c85b1b7b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911\u20139.","DOI":"10.1161\/CIRCULATIONAHA.111.054361"},{"key":"2023010208471973711_j_cclm-2015-0890_ref_011_w2aab2b8c85b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 27:2015. JASN ASN.2015020157.","DOI":"10.1681\/ASN.2015020157"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0890\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0890\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T09:06:33Z","timestamp":1672650393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0890\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,12,7]]},"published-print":{"date-parts":[[2016,7,1]]}},"alternative-id":["10.1515\/cclm-2015-0890"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2015-0890","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,18]]}}}